* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download outline21590
Epigenetics of human development wikipedia , lookup
Population genetics wikipedia , lookup
Minimal genome wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Gene nomenclature wikipedia , lookup
Medical genetics wikipedia , lookup
Point mutation wikipedia , lookup
Oncogenomics wikipedia , lookup
Pathogenomics wikipedia , lookup
Human genetic variation wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Gene desert wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Genomic imprinting wikipedia , lookup
Gene expression programming wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Gene expression profiling wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Genome editing wikipedia , lookup
Genome evolution wikipedia , lookup
Genetic engineering wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
History of genetic engineering wikipedia , lookup
Public health genomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Genome (book) wikipedia , lookup
Clinical Essentials of Ophthalmic Genetics I. What makes a disease hereditary? II. Family History A. What to ask B. How to ask it III. Pedigree Construction A. How to elicit the information B. How to draw it C. Clinical examples IV. Modes of Inheritance A. Autosomal dominant B. Autosomal recessive C. X-linked recessive D. Maternal inheritance E. Other Modes of Inheritance 1. X-linked dominant 2. Co-dominant 3. Uniparental disomy 4. Genomic imprinting 5. Horizontal gene transfer 6. “Jumping genes” 7. Digenic inheritance V. Genetic Testing A. DNA Primer B. Human Genome Project (HGP) 1. Historical Overview and Outcomes a. Initiated by Department of Energy b. Human Genome Initiative 1986 c. HGP began 1990 d. Joint effort by DOE and NIH e. Estimated completion 15 years f. Working draft announced June 2000 2. HGP - Working Draft a. 16 Sequencing centers b. 22.1 billion bases of raw data c. 30% high quality finished sequence d. Map of 90% of genes on every chromosome e. 3164.7 million bases f. Only about 35,000 genes!! g. Avg. gene is 3,000 bases h. Largest is 2.4 million i. All data rapidly available on Web C. Retinal Disease Genes 1. Can only test for known mutations a. Research studies may discover new mutations 2. A negative only means that a known mutation was not found 3. A positive offers little help until there is treatment 4. Resource – GeneTests website VI. Ophthalmic Examples A. Retinitis Pigmentosa 1. Autosomal dominant 2. Autosomal recessive 3. X-linked recessive B. Leber hereditary optic neuropathy C. Glaucoma 1. OcugeneTM Test D. Unknown retinal dystrophy E. Retinal Dystrophy VII. Genetic Counseling A. Legal precedents B. Negligent Acts Claimed by Plaintiffs 1. Failure to take a family history 2. Failure to identify high risks 3. Failure to perform diagnostic tests 4. Failure to provide counseling 5. Misdiagnosis of a previous child 6. Missed diagnosis of a previous child 7. Laboratory errors C. Wrongful Birth D. Wrongful Life E. Economic Harm F. Non-Economic Harm 1. Emotional pain and suffering G. What the genetic counselor must know 1. Exact diagnosis 2. Risk estimate 3. Prognosis 4. Alternatives: Pre-conception and post-conception 5. Exact Diagnosis 6. Physical examination 7. Laboratory studies 8. Family studies 9. Study of previous abortus or stillborn 10. Molecular genetic analysis 11. Risk Estimate a. How big a risk is 25%? b. 25% risk means 75% normal which may sound good c. It depends on the prognosis (1) How will the offspring be different as an adolescent or as an adult? d. Parents must make a decision about future children before current child has manifested the expected sequelae 12. Pre-Conception Alternatives 13. Post-Conception Alternatives VIII. Gene therapy A. Barriers to therapy 1. Targeting 2. Effectivity B. Genetic manipulation of embryo C. Ethical issues D. Germline Gene therapy 1. Preconception manipulation of egg of sperm E. Somatic Gene Therapy F. In Vivo and In Situ Gene Therapy G. Viral delivery vehicles H. Non-viral delivery vehicles 1. delivery 2. Gene gun I. Ophthalmic Gene Therapy 1. Lancelot dog model IX. eyeGENE Initiative from NEI A. Repository of DNA from patients with hereditary eye disease B. Correlated phenotypic description C. Contributors will be patients of ODs and MDs D. How it will help X. Resources for the Practitioner A. Entrez 1. http://www.ncbi.nlm.nih.gov/Database/index.html B. PubMed 1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi C. OMIM 1. http://www.ncbi.nlm.nih.gov/omim/ D. HUGO 1. http://www.hugo-international.org/ E. RetNet 1. http://www.sph.uth.tmc.edu/Retnet/ F. GeneTests 1. http://www.geneclinics.org/ G. NEI Trials 1. http://www.nei.nih.gov/neitrials/ H. ClinicalTrials.gov 1. http://clinicaltrials.gov/ct/gui I. eyeGENE 1. http://www.nei.nih.gov/resources/eyegene.asp